These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1759 related articles for article (PubMed ID: 27013694)
1. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694 [TBL] [Abstract][Full Text] [Related]
2. Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry. Vrablik M; Raslová K; Vohnout B; Blaha V; Satny M; Kyselak O; Vaclova M; Urbanek R; Maskova J; Soska V; Freiberger T Atherosclerosis; 2018 Oct; 277():355-361. PubMed ID: 30270071 [TBL] [Abstract][Full Text] [Related]
3. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)? Kayikcioglu M; Tokgozoglu L; Dogan V; Ceyhan C; Tuncez A; Kutlu M; Onrat E; Alici G; Akbulut M; Celik A; Yesilbursa D; Sahin T; Sonmez A; Ozdogan O; Temizhan A; Kilic S; Bayram F; Sabuncu T; Coskun FY; Ildizli M; Durakoglugil E; Kirilmaz B; Yilmaz MB; Yigit Z; Yildirim AB; Gedikli O; Topcu S; Oğuz A; Demir M; Yenerçağ M; Yıldırır A; Demircan S; Yilmaz M; Kaynar LG; Aktan M; Durmus RB; Gokce C; Ozcebe Oİ; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O; Can LH Atherosclerosis; 2018 Oct; 277():341-346. PubMed ID: 30270069 [TBL] [Abstract][Full Text] [Related]
4. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice. Vohnout B; Fábryová Ľ; Klabník A; Kadurová M; Bálinth K; Kozárová M; Bugáňová I; Sirotiaková J; Rašlová K Atherosclerosis; 2018 Oct; 277():323-326. PubMed ID: 30270066 [TBL] [Abstract][Full Text] [Related]
5. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P; J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947 [TBL] [Abstract][Full Text] [Related]
6. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry. Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356 [TBL] [Abstract][Full Text] [Related]
7. Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry. de Ferranti SD; Shrader P; Linton MF; Knowles JW; Hudgins LC; Benuck I; Kindt I; O'Brien EC; Peterson AL; Ahmad ZS; Clauss S; Duell PB; Shapiro MD; Wilemon K; Gidding SS; Neal W J Pediatr; 2021 Feb; 229():70-77. PubMed ID: 32976895 [TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization. Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350 [TBL] [Abstract][Full Text] [Related]
9. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service. Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442 [TBL] [Abstract][Full Text] [Related]
10. Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry. Schmidt N; Dressel A; Grammer TB; Gouni-Berthold I; Julius U; Kassner U; Klose G; König C; Koenig W; Otte B; Parhofer KG; Reinhard W; Schatz U; Schunkert H; Steinhagen-Thiessen E; Vogt A; Laufs U; März W Atherosclerosis; 2018 Oct; 277():314-322. PubMed ID: 30270065 [TBL] [Abstract][Full Text] [Related]
11. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064 [TBL] [Abstract][Full Text] [Related]
12. High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry. Béliard S; Boccara F; Cariou B; Carrié A; Collet X; Farnier M; Ferrières J; Krempf M; Peretti N; Rabès JP; Varret M; Vimont A; Charrière S; Bruckert E; Atherosclerosis; 2018 Oct; 277():334-340. PubMed ID: 30270068 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry. Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564 [TBL] [Abstract][Full Text] [Related]
14. Latvian registry of familial hypercholesterolemia: The first report of three-year results. Latkovskis G; Saripo V; Gilis D; Nesterovics G; Upena-Roze A; Erglis A Atherosclerosis; 2018 Oct; 277():347-354. PubMed ID: 30270070 [TBL] [Abstract][Full Text] [Related]
15. LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C. van Delden XM; Huijgen R; Wolmarans KH; Brice BC; Barron JK; Blom DJ; Marais AD Atherosclerosis; 2018 Oct; 277():327-333. PubMed ID: 30270067 [TBL] [Abstract][Full Text] [Related]
16. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction. Singh A; Gupta A; Collins BL; Qamar A; Monda KL; Biery D; Lopez JAG; de Ferranti SD; Plutzky J; Cannon CP; Januzzi JL; Di Carli MF; Nasir K; Bhatt DL; Blankstein R J Am Coll Cardiol; 2019 May; 73(19):2439-2450. PubMed ID: 31097165 [TBL] [Abstract][Full Text] [Related]
17. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study). Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P; Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014). Bucholz EM; Rodday AM; Kolor K; Khoury MJ; de Ferranti SD Circulation; 2018 May; 137(21):2218-2230. PubMed ID: 29581125 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening. Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386 [TBL] [Abstract][Full Text] [Related]
20. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers. Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]